We would love to hear your thoughts about our site and services, please take our survey here.
I am adding few points to my previous 2 messages The Nasdaq listing and It is a Duck
Conduit strategy is to licence drugs from other pharmaceutical companies and take them to clinic but it will do that using third parties (I think TRX is that third party)
Conduit will enter into service agreements with CROs to conduct and oversee it is clinic trial but it will do that using third parties (TRX entered into service agreements with valirxt to do just that)
I think TRX is just an SPV Created by conduit to play the role of third party.
I think conduit is the driver behind all this, and the time line as follows:
*2019 conduit registered in Cayman Island
*2020 TRX incorporated in Delaware
*2021 Murphy Canyon incorporated in Delaware
*2022 Murphy Canyon listed on the Nasdaq
*2023
I think the road is now been paved for this deal to go ahead
Suzy in the Q&A said if the deal is not going to be signed by year-end shareholders would have already been informed, and she also said we are in regular contact with them to find out what they are doing and what is their time scale, so mention what so ever of funds raise
As I said before if it looks like a duck, walks and quacks then probably is a Duck.
Just did my final top-up just over 83k
Good luck to us all, and see you after the RNs land which I think it will be well before the year-end.
Off now to earn some bread and butter
I am revisiting the NASDAQ listing Train of thought which I raised on my previous message adding bits and pieces here and there.
1-on 28/10/2020 TRX incorporated in Delaware with the purpose licensing compounds from other pharmaceutical companies and take them to clinic.
https://opencorporates.com/companies/us_de/4000340#:~:text=in/Sign%20up-,THEOREMRX%2C%20INC,-
2-on 19/10/2022 Murphy Canyon corp incorporated Delaware with the purpose merger and acquisition of assets
https://opencorporates.com/companies/us_de/6320301#:~:text=in/Sign%20up-,MURPHY%20CANYON%20ACQUISITION%20CORP,-
3-Just few days later on 2/11/2021 TRX RNA to sign our asset
4-on 2/3/2022 Murphy Canyon listed on the Nasdaq under the Industry: biotechnology (pharmaceutical preparations) after an IPO rasing 132.250.000
5-Murphy Canyon then went ahead and acquired a Cayman Island registered company by the name of conduit pharmaceuticals (who already have 3 deprioritised drugs licensed to them from AZ) with the aim of merging the 2 companies.
6- Murphy Canyon/conduit have an agreement to licence three other drugs (no mention what they are and from whom) but haven't been licensed yet.
6-TRX have an agreement to licence 201 but haven't been licensed yet
7- I personally think Murphy Canyon will not enter into a binding agreement to licence those drugs only if and until the merger is finalised.
8-Murphy Canyon/conduit merger was expected to be completed last year but it was delayed
9-TRX agreement with Val was expected to be signed last year but it was delayed
Both TRX and Murphy Canyon/conduit strategy is to licence drugs from other pharma and take them to clinic.
The merger with conduit have been facing numerous hurdles specially in the last few weeks but today the final line is about to be crossed when Murphy Canyon shareholders will be voting for the merger , and it looks like there is a leak judging by the jump in the share price yesterday.
There is too much similarities to make me raise if not 2 at least 1 eyebrow.
This whole thing seems to me it looks like a duck.walk like a duck and quark like a duck but... what is it?
Https://www.sec.gov/ix?doc=/Archives/edgar/data/1896212/000149315223016741/forms-4.htm#:~:text=D.C.%2020549-,FORM,-S%2D4
This is From s-4 issued on the 12,/5 /2023
Murphy Canyon acquisition corp a NASDAQ listed company acquired a Cayman Islands registered company by the name of conduit pharmaceuticals limited
On 19/ 10/2021 a company by the name of conduit pharmaceuticals Inc was incorporated in Delaware
On 2/11/2021 (less than 2 weeks) valirx issued an RNA regarding TRX letter.
Both Murphy Canyon and TRX strategy is to take peptides and deprioritize compounds from other pharma to clinic.
Once the merger with Conduit completed Murphy Canyon will be delisted and the shareholders will become the owners of the new company and it will be listed on the Nasdaq, but Murphy Canyon requested from the shareholders to vote for a dealy of the listing and it was granted.
Today Valirx informed us that the deal was expected to be completed last year but there was a dealy
On 12/5/2023 Murphy Canyon issued Form S-4 signaling the starting process of the listing which is likely to take weeks rather than months.
I have strong feelings that TRX is just a cover used by Murphy Canyon/Conduit to go around shopping for compounds before the listing .
I am %75 confidence that the deal is happening with this company , the timing the similarities the location can not all be just coincidences, and I think Suzie will not be giving TRX all this time if she didn't see strong evidence the deal is happening, she knows her reputation and probably her job is on the line here.
As a result of all I decided to do 2 cheeky top ups today something I thought I will never do again,one at 9/17 for 43511 shares but it was shown as sell , the other one at 14/25 for 3198. And when I get home I will have a look under the sofa I am sure I have some money there.
Anyone willing and have the time to do more digging can start by going to Murphy canyon acquisition corp website.
A new pharmaceutical company is about to be listed on the Nasdaq, could TRX and our 201 be part of their pipeline, maybe that is where Suzie confidence and unconcerned come from.
https://murphycanyonac.com/conduit-pharmaceuticals-to-become-a-publicly-traded-company-via-merger-with-murphy-canyon-acquisition-corp/#:~:text=Press-,Release,-November%209%2C%202022
Adam is not just our major shareholder but more importantly he is the company major brain holder, and if he is not happy with the direction of those lots ,it will be better if he remains calm and try to communicate with the company directly because if he start airing his anger publicly the share price will sink below 10p, we are lucky to have him as major shareholder he gives a degree of assuredness to to the market, without his present we will be trading at 5p probably
Hi Adam C4X partnered 3 of their drugs 2 of them preclinical and 1 in phase 1 and they will get 1.1 billion for them. So there is good money to be made on preclinical deals,but what is shocking is they have a market capitalisation a round 40million.
This is from an RNS issued on 26/3/2019,and here is what Suzy said
https://www.lse.co.uk/rns/VAL/valiseek-update-j8mxlwx08lax2gy.html#:~:text=Dr%20Suzanne%20Dilly,final%20clinical%20trials%22
I am starting to wander were are we going
Few millions shares available for borrowing.do lom do those kind of things. I guess they must be shorters out there but below the % required to be reported in short tracker
https://iborrowdesk.com/report/NANO.LN#:~:text=NANOCO-,GROUP,-PLC%20%2D%20NANO
The CEO need to do interview with proactive or brrmedia to sort out this confusion they created.this is the most important event in the company's past, present and future and yet somehow they managed to mess it up . very amateurish